Neurocrine Biosciences reported $1.21B in Current Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US USD 521.55M 10.97M
Agios Pharmaceuticals AGIO:US USD 784.94M 85.07M
ALKERMES ALKS:US USD 1.05B 7.81M
Alnylam Pharmaceuticals ALNY:US USD 2.69B 219.21M
Amgen AMGN:US USD 24.06B 4.74B
Aptinyx Inc APTX:US USD 73.95M 18.19M
Biogen BIIB:US USD 9.77B 24.9M
Biomarin Pharmaceutical BMRN:US USD 2.68B 165.1M
Cytokinetics CYTK:US USD 884.28M 282.02M
Enanta Pharmaceuticals ENTA:US USD 311.71M 1.32M
Exelixis EXEL:US USD 1.84B 10.02M
Gilead Sciences GILD:US USD 13.9B 723M
Halozyme Therapeutics HALO:US USD 653.2M 111.26M
Intercept Pharmaceuticals ICPT:US USD 545.37M 58.36M
Intra Cellular Therapies ITCI:US USD 759.76M 29.45M
IONIS PHARMACEUT IONS:US USD 2.15B 39.02M
Nektar Therapeutics NKTR:US USD 599.48M 66.05M
Neurocrine Biosciences NBIX:US USD 1.21B 186.2M
Prothena PRTA:US USD 524.56M 3.27M
Regeneron Pharmaceuticals REGN:US USD 15.43B 101.3M
Repligen RGEN:US USD 953.23M 22.76M
Rigel Pharmaceuticals RIGL:US USD 110.44M 10.08M
Sarepta Therapeutics SRPT:US USD 2.63B 156.63M
Teva Pharmaceutical TEVA:IT USD 11.45B 711M
Ultragenyx Pharmaceutical RARE:US USD 1.01B 334.13M
Vertex Pharmaceuticals VRTX:US USD 12.27B 767.5M
Xoma XOMA:US USD 79.74M 7.52M
YTE INCY:US USD 3.82B 195.27M